A wspA mutation in a clinical isolate of Pseudomonas aeruginosa results in rugose small colonies and enhances biofilm formation
Microbiology Spectrum · 03.11.2026 · 14 (11)
DOI: 10.1128/spectrum.00530-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 03.11.2026. Verfasst von Qing Yu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Biofilms, Pseudomonas aeruginosa, Bacterial Proteins, Pseudomonas Infections. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pseudomonas aeruginosa is a major multidrug-resistant pathogen whose biofilm formation complicates treatment. R ugose s mall c olony v ariants (RSCVs) exhibit enhanced biofilm production and resistance, posing significant clinical challenges; however, their formation mechanisms in clinical strains remain incompletely understood. Paired clinical isolates AR8023-1 (wild type) and AR8023-2 (RSCV) were chronologically collected from urine samples of a neurosurgery inpatient. Genome comparison via Breseq and plasmid complementation constructed the complemented strain AR8023-2 RifR :: wspA AR8023-1 . All strains were examined for RSCV phenotype, biofilm formation, motility, transcriptomic changes, c-di-GMP quantification, and antimicrobial susceptibility under planktonic and biofilm conditions. Both isolates were identified as ST3420. AR8023-1 exhibited typical smooth morphology, while AR8023-2 displayed an RSCV phenotype with a single SNP—a glutamine deletion at position 289 (ΔQ289) in WspA. Complementation restored wild-type morphology, motility, and biofilm formation. Transcriptomics revealed significant upregulation of c-di-GMP metabolic genes in RSCVs ( P < 0.001), suggesting that WspAΔQ289 increases diguanylate cyclase activity and elevates c-di-GMP synthesis. Intracellular c-di-GMP levels were ~3-fold higher in RSCVs than in wild-type and complemented strains ( P < 0.001). Biofilm susceptibility testing demonstrated that β-lactam MBICs for RSCVs were 8- to 512-fold higher than those of wild-type and complement isolates. Introduction of the same WspAΔQ289 allele into P. aeruginosa PAO1 did not recapitulate the RSCV phenotype, indicating that strain background contributes to the phenotypic outcome. This study confirms and extends the role of a clinical WspAΔ289Q mutation that elevates c-di-GMP, driving RSCV formation and biofilm-mediated resistance. IMPORTANCE This study further characterizes a specific WspAΔ289Q mutation in clinical Pseudomonas aeruginosa that is associated with activation of the c-di-GMP pathway, driving rugose small colony variant (RSCV) formation and hyper-biofilm phenotypes. The mutation markedly enhances biofilm-mediated β-lactam resistance, which is consistent with treatment failure. Complementation restores wild-type traits, supporting the importance of WspA structural integrity as a key regulator of colony morphology and antibiotic tolerance. These findings provide a molecular biomarker for RSCV surveillance and highlight c-di-GMP signaling as a therapeutic target against biofilm-associated chronic infections, although the phenotype is strain-dependent and the mutation occurs in a previously identified WspA hotspot.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province, Hangzhou, China.
- Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Critical Care Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Medical Laboratory, Ningbo Medical Center Lihuili Hospital, Ningbo, China.
- Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
ORCID-Profile: Qing Yu, Linyue Zhang, Xiaoting Hua, Yunsong Yu, Qiucheng Shi, Xiaoxing Du
Zitieren
APA
Yu, Q., Li, Y., Wang, P., Zhang, C., Ni, H., Zhang, Y., Cui, Y., Zhou, M., Ni, J., Zhang, L., Hua, X., Yu, Y., Shi, Q., & Du, X. (2026). A wspA mutation in a clinical isolate of Pseudomonas aeruginosa results in rugose small colonies and enhances biofilm formation. Microbiology Spectrum, 14(11). https://doi.org/10.1128/spectrum.00530-26
Vancouver
Yu Q, Li Y, Wang P, Zhang C, Ni H, Zhang Y, et al. A wspA mutation in a clinical isolate of Pseudomonas aeruginosa results in rugose small colonies and enhances biofilm formation. Microbiology Spectrum. 2026;14(11). doi:10.1128/spectrum.00530-26
BibTeX
@article{Yu2026,
author = {Yu, Qing and Li, Yue and Wang, Peiqi and Zhang, Chen and Ni, Hanming and Zhang, Yisha and Cui, Yushan and Zhou, Mengyu and Ni, Jun and Zhang, Linyue and Hua, Xiaoting and Yu, Yunsong and Shi, Qiucheng and Du, Xiaoxing},
title = {A wspA mutation in a clinical isolate of Pseudomonas aeruginosa results in rugose small colonies and enhances biofilm formation},
journal = {Microbiology Spectrum},
year = {2026},
volume = {14},
number = {11},
doi = {10.1128/spectrum.00530-26}
}
EUVIMED